Clinical Trial Update: Leflunomide in Treating Patients With Relapsed or Refractory Multiple Myeloma [Phase 1, Phase 2]

View source ↗

Summary

A phase 1/2 clinical trial evaluating leflunomide in patients with relapsed or refractory multiple myeloma has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• Leflunomide (Leflunomide)

Snippet

Sponsor: City of Hope Medical Center | Conditions: Recurrent Plasma Cell Myeloma, Refractory Plasma Cell Myeloma | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2023-10-10